U.S. Markets open in 7 hrs 31 mins

Conatus reports 4Q loss

SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Wednesday reported a loss of $9.1 million in its fourth quarter.

On a per-share basis, the San Diego-based company said it had a loss of 35 cents.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.

The biotechnology company posted revenue of $799,000 in the period.

For the year, the company reported a loss of $29.7 million, or $1.31 per share. Revenue was reported as $799,000.

In the final minutes of trading on Wednesday, the company's shares hit $4.91. A year ago, they were trading at $1.90.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNAT at https://www.zacks.com/ap/CNAT


Keywords: Conatus Pharmaceuticals, Earnings Report